Gapping up
In reaction to strong earnings/guidance: CGA +1%, SYNA +0.5%
M&A news: SLH +9.5% (to be acquired by Vista Equity Partners for $55.85 per share in cash), CHS +7.8% (considering sale following private equity interest, according to Bloomberg), NOK +1.7% (Nokia receives CFIUS clearance for proposed acquisition of Alcatel-Lucent; added to Conviction Buy list at Goldman), ALU +1.7%
Other news: COLL +37.5% (reports FDA unanimous recommendation for approval of Xtampza ER), AQXP +24.3% ( Baker Bros discloses purchase of ~2.48 mln shares of common stock at $15.50 per share; Purchase was part of the previously announced offering of 5.5 mln shares; Baker Bros maintains ~40% stake in the company), GERN +5.7% (cont strength coming out of Friday), ACTS +3.1% (amends Dutch Auction tender offer; reaffirms guidance for Q3 revs of $13-14 mln, but expects FY15 revs to growth at a slower pace than previously expected), PIRS +2.3% (Global Life Bioventure discloses 6.25% passive stake in 13G filing), MBLY +2% (rebounding modestly following last weeks selloff), AN +1.3% (authorizes additional $250 mln for share repurchase), WMB +0.7% (increases quarterly dividend 8.5% QoQ to $0.64 per share)
Analyst comments: VRTX +1.5% (upgraded to Overweight from Equal Weight at Barclays ), AAPL +1.3% (positive commets from FBR; iPhone 6s pre-orders off to a strong start led by China), GPRO +0.8% (positive comments at Northland), AZN +0.6% (upgraded to Buy from Hold at Deutsche Bank)